Determination of Risk Factors Associated with the Failure of 12 Weeks of Direct-Acting Antiviral Therapy in Patients with Hepatitis C: A Prospective Study

INTRODUCTION: Direct-acting antivirals (DAAs) have significantly improved the efficacy and tolerability of the treatment of hepatitis C virus (HCV). However, studies conducted on actual patients with the aim of predicting the risk associated with treatment failure are lacking. METHODS: Our study enr...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen Thi Thu, Phuong, Ngo Thi Quynh, Mai, Pham Van, Linh, Nguyen Van, Hung, Nguyen Thanh, Hoi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106452/
https://www.ncbi.nlm.nih.gov/pubmed/35572735
http://dx.doi.org/10.1155/2022/6054677

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106452/
https://www.ncbi.nlm.nih.gov/pubmed/35572735
http://dx.doi.org/10.1155/2022/6054677

Ejemplares similares